Breaking news: F.D.A. approves weight loss drug to treat obstructive sleep apnea

Zepbound is the first prescription drug approved specifically to treat the common condition.

View in browser Dec. 20, 2024, 5:22 p.m. ET BREAKING NEWS Dustin Chambers for The New York Times F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder. Read more Need help? Review our newsletter help page or contact us for assistance. You received this email because you signed up for Breaking News from The New York Times. To stop receiving Breaking News, unsubscribe. To opt out of other promotional emails from The Times, including those regarding The Athletic, manage your email settings. To opt out of updates and offers sent from The Athletic, submit a request. Subscribe to The TimesGet The New York Times app Connect with us on: Change Your EmailPrivacy PolicyContact UsCalifornia Notices The New York Times Company. 620 Eighth Avenue New York, NY 10018